nifedipine has been researched along with Acute Edematous Pancreatitis in 6 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study failed to demonstrate a significant effect of nifedipine in the prevention of post-ERCP pancreatitis." | 9.10 | Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. ( Amaris, J; Bocquentin, M; Buffet, C; Choury, AD; Ducot, B; Fritsch, J; Pelletier, G; Prat, F, 2002) |
| "The aim of this paper was to evaluate the influence of nifedipine (calcium channel blocker) and Bay-K-8644 (calcium channel agonist) on cerulein acute pancreatitis (AP) in rats." | 7.71 | The influence of nifedipine (calcium channel blocker) and Bay-K-8644 (calcium channel agonist) on the development of experimental acute pancreatitis. ( Celiński, K; Cichoz-Lach, H; Czerny, K; Kleinrok, Z; Słomka, M; Wargocki, J, 2001) |
| "This study failed to demonstrate a significant effect of nifedipine in the prevention of post-ERCP pancreatitis." | 5.10 | Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. ( Amaris, J; Bocquentin, M; Buffet, C; Choury, AD; Ducot, B; Fritsch, J; Pelletier, G; Prat, F, 2002) |
| "The aim of this paper was to evaluate the influence of nifedipine (calcium channel blocker) and Bay-K-8644 (calcium channel agonist) on cerulein acute pancreatitis (AP) in rats." | 3.71 | The influence of nifedipine (calcium channel blocker) and Bay-K-8644 (calcium channel agonist) on the development of experimental acute pancreatitis. ( Celiński, K; Cichoz-Lach, H; Czerny, K; Kleinrok, Z; Słomka, M; Wargocki, J, 2001) |
| "Nifedipine was used as the antagonist of MCP-1." | 1.38 | Experimental pancreatitis results in increased blood-brain barrier permeability in rats: a potential role of MCP-1. ( Ding, Z; Hou, XH; Lin, R; Liu, J, 2012) |
| "In all patients with acute pancreatitis, the diagnosis of malignant hypertension should be considered." | 1.28 | Malignant hypertension presenting as acute pancreatitis. ( Mathur, R; Warren, JP, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, WD | 1 |
| Sherman, S | 1 |
| Ding, Z | 1 |
| Liu, J | 1 |
| Lin, R | 1 |
| Hou, XH | 1 |
| Prat, F | 1 |
| Amaris, J | 1 |
| Ducot, B | 1 |
| Bocquentin, M | 1 |
| Fritsch, J | 1 |
| Choury, AD | 1 |
| Pelletier, G | 1 |
| Buffet, C | 1 |
| Sand, J | 1 |
| Nordback, I | 1 |
| Słomka, M | 1 |
| Celiński, K | 1 |
| Wargocki, J | 1 |
| Kleinrok, Z | 1 |
| Czerny, K | 1 |
| Cichoz-Lach, H | 1 |
| Mathur, R | 1 |
| Warren, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00121901] | Phase 3 | 1,600 participants (Anticipated) | Interventional | 2004-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nifedipine and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Endoscopic approach to the patient with motility disorders of the bile duct and sphincter of Oddi.
Topics: Bile Ducts; Botulinum Toxins, Type A; Cholangiopancreatography, Endoscopic Retrograde; Dilatation; H | 2013 |
2 trials available for nifedipine and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Calcium Channel Blockers; Cholangiopancreatography, E | 2002 |
Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
Topics: Abdominal Pain; Acute Disease; Biliary Tract Diseases; Cholangiopancreatography, Endoscopic Retrogra | 1993 |
3 other studies available for nifedipine and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Experimental pancreatitis results in increased blood-brain barrier permeability in rats: a potential role of MCP-1.
Topics: Acute Disease; Animals; Blood-Brain Barrier; Calcium Channel Blockers; Chemokine CCL2; Evans Blue; M | 2012 |
The influence of nifedipine (calcium channel blocker) and Bay-K-8644 (calcium channel agonist) on the development of experimental acute pancreatitis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2001 |
Malignant hypertension presenting as acute pancreatitis.
Topics: Acute Disease; Adult; Alcohol Drinking; Humans; Hypertension, Malignant; Male; Nifedipine; Pancreati | 1989 |